NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.

Cover of GeneReviews®

GeneReviews® [Internet].

Show details

Saethre-Chotzen Syndrome

Synonym: Acrocephalosyndactyly Type III

, MD, MPH, , DDS, PhD, and , MD, PhD.

Author Information

Initial Posting: ; Last Revision: June 14, 2012.


Clinical characteristics.

Classic Saethre-Chotzen syndrome (SCS) is characterized by coronal synostosis (unilateral or bilateral), facial asymmetry (particularly in individuals with unilateral coronal synostosis), ptosis, and characteristic appearance of the ear (small pinna with a prominent crus). Syndactyly of digits two and three of the hand is variably present. Intelligence is usually normal, although those with large genomic deletions are more likely to have developmental delays. Less common manifestations of SCS include short stature, parietal foramina, vertebral fusions, radioulnar synostosis, cleft palate, maxillary hypoplasia, ocular hypertelorism, hallux valgus, duplicated distal hallucal phalanx, and congenital heart malformations.


The diagnosis of SCS is primarily based on clinical findings. TWIST1 is the only gene in which pathogenic variants are known to cause SCS. Occasionally, affected individuals have a chromosome translocation involving 7p21 or ring chromosome 7.


Treatment of manifestations: Cranioplasty in the first year of life to prevent progressive facial asymmetry in those with asymmetric coronal fusion and to prevent increased intracranial pressure (ICP) in those with multiple sutural synostosis; midfacial surgery as needed for dental malocclusion, swallowing difficulties, and respiratory problems. If a cleft palate is present, surgical repair usually follows cranioplasty. As needed: orthodontic treatment and/or orthognathic surgery at the completion of facial growth; developmental intervention; routine treatment of hearing loss; ophthalmologic evaluation and, if ptosis is present, intervention to prevent amblyopia, with surgical repair during early childhood as needed.

Prevention of secondary complications: Attention to possible cervical vertebral instability secondary to vertebral anomalies.

Surveillance: Periodic ophthalmologic evaluation for chronic papilledema, strabismus, or amblyopia, or brain imaging in later life for evidence of increased intracranial pressure (ICP); routine re-evaluation for facial asymmetry, psychomotor development, and hearing loss.

Genetic counseling.

SCS is inherited in an autosomal dominant manner. Many individuals diagnosed with SCS have an affected parent; the proportion of cases caused by a de novo pathogenic variant is unknown. Each child of an individual with SCS has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant has been identified in the family; however, requests for prenatal testing for conditions such as SCS are not common.


Clinical Diagnosis

With the ability to detect pathogenic variants in TWIST1, the phenotypic spectrum of Saethre-Chotzen syndrome (SCS) is becoming increasingly broad: phenotypes that are both milder and more severe than classic SCS are recognized.

The clinical diagnosis of SCS is made primarily on the following clinical findings:

  • Craniosynostosis (premature fusion of one or more sutures of the calvarium). The coronal suture is the most commonly affected, although any or all sutures can be affected. Craniosynostosis often presents with an abnormal skull shape (e.g., brachycephaly [short, broad skull] and acrocephaly [tall skull]).
  • Low frontal hairline, ptosis, strabismus, facial asymmetry
  • Small ears with a prominent crus
  • Limb anomalies including brachydactyly, partial cutaneous syndactyly of the second and third digits of the hand, hallux valgus, duplicated distal phalanx of the hallux, triangular epiphyses of the hallux [Trusen et al 2003]
    Note: Although the degree of syndactyly or its presence is highly variable, it is effectively diagnostic in the presence of the first three features.


Cytogenetic testing. Translocations, inversions, or ring chromosome 7 involving 7p21 have been reported in individuals with SCS with atypical findings, including developmental delay [Shetty et al 2007, Touliatou et al 2007].

Molecular Genetic Testing

Gene. TWIST1 is the only gene in which pathogenic variants are known to cause SCS.

Clinical testing

Table 1.

Summary of Molecular Genetic Testing Used in Saethre-Chotzen Syndrome

Gene 1Test MethodPathogenic Variants Detected 2Variant Detection Frequency by Test Method 3
TWIST1Sequence analysis of coding region 4Sequence variants in exon5>50%68% 6
Deletion/ duplication analysis 7Exon or whole-gene deletions11% 8 - 28% 9
Cytogenetic/FISHTranslocations/inversions involving 7p213.6% 6

See Molecular Genetics for information on allelic variants.


The ability of the test method used to detect a variant that is present in the indicated gene


Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click here.


All intragenic pathogenic variants identified to date are in exon 1, which contains the entire coding region.


In 37 individuals with classic features of SCS (test method not specified) [Cai et al 2003a]


Testing that identifies exon or whole-gene deletions/duplications not readily detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA; included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.


Testing Strategy

To confirm/establish the diagnosis in a proband. Confirmation of the diagnosis in a proband requires identification of a TWIST1 pathogenic variant using the following approach:

Prenatal diagnosis and preimplantation genetic diagnosis for at-risk pregnancies require prior identification of the pathogenic variant in the family.

Clinical Characteristics

Clinical Description

With the ability to detect pathogenic variants in TWIST1, the phenotypic spectrum of Saethre-Chotzen syndrome (SCS) is becoming increasingly broad. Both milder and more severe phenotypes are recognized.

Classic Saethre-Chotzen syndrome is characterized by coronal synostosis (unilateral or bilateral), facial asymmetry (particularly in individuals with unicoronal synostosis), strabismus, ptosis, and characteristic appearance of the ear (small pinna with a prominent superior and/or inferior crus). It is important to note that other sutures (i.e., sagittal, lambdoid, and metopic) can undergo premature fusion in individuals with SCS and that individuals with SCS with no evidence of pathologic suture fusion have been described.

Partial cutaneous syndactyly of digits two and three of the hand and duplication of the distal hallux are variably present. Less common (but clinically significant) findings include both conductive and sensorineural hearing loss and segmentation defects of the vertebrae. Whereas mild-to-moderate developmental delay and intellectual disability have been reported, normal intelligence is more common.

Less common manifestations of SCS include short stature, parietal foramina, radioulnar synostosis, cleft palate, maxillary hypoplasia, ocular hypertelorism, hallux valgus, and congenital heart malformations.

Other findings variably present:

  • Lacrimal duct stenosis, vertebral fusion, and short stature [Anderson et al 1997, Trusen et al 2003]
  • Family history of abnormal skull shape and/or a combination of other physical findings. Although usually present in SCS, craniosynostosis is not an obligatory finding; therefore, affected relatives may not have been diagnosed with a craniosynostosis syndrome.
  • Intellectual disability. Although learning differences may be noted in persons with intragenic pathogenic variants, severe delay or intellectual disability is not typical. In contrast, individuals with a microdeletion in 7p21 usually show significant learning deficits.
  • Conductive, mixed, and profound sensorineural hearing loss [Lee et al 2002]
  • Palatal anomalies, including narrow palate, bifid uvula, and cleft palate, [Stoler et al 2009]
  • Increased intracranial pressure (ICP). A recent study found that 21% of individuals with SCS had increased ICP based on the finding of papilledema that persisted more than one year after surgery [de Jong et al 2010].
  • Obstructive sleep apnea (OSA). Mild obstructive sleep apnea (OSA), defined by changes in nocturnal oxygen saturation, was diagnosed in 5% of individuals with SCS in one recent study [de Jong et al 2010].

A more severe phenotype, indistinguishable from that of Baller-Gerold syndrome (BGS) (see Differential Diagnosis), has been observed. This phenotype includes severe craniosynostosis, radial ray hypoplasia/agenesis, vertebral segmentation defects, and other anomalies [Gripp et al 1999, Seto et al 2001]. Two individuals with clinical features consistent with BGS were found to have novel TWIST1 pathogenic variants.

Milder phenotypes associated with TWIST1 pathogenic variants include the following:

One case series suggested an increased risk for breast cancer in women with SCS [Sahlin et al 2007]; however, a subsequent study failed to support this claim [James et al 2009].

Genotype-Phenotype Correlations

Most pathogenic variants causing SCS are intragenic and cause haploinsufficiency of the protein product, Twist-related protein 1.

With the exception of pathogenic variants identified in the TWIST box, no conclusive evidence of genotype-phenotype correlations exists despite the identification of pathogenic variants in each of the functional domains of the Twist-related protein 1 (5' DNA binding, DNA binding, helix 1, loop, and helix 2 domains). Pathogenic variants in the TWIST box, the highly conserved C-terminus that binds and inhibits RUNX2 transactivation, have been shown to be associated with a milder phenotype of isolated sagittal or unilateral coronal synostosis (see Genetically Related Disorders).

Although insertions, deletions, and pathogenic nonsense and missense variants have been described, no genotype-phenotype correlation has been found, suggesting that sequence alterations lead to a loss of functional TWIST1 protein irrespective of the variant type.

The vast majority of individuals with single-nucleotide variants have normal intelligence. The risk for developmental delay in individuals with deletions involving TWIST1 is approximately 90%, or eightfold, greater than in individuals with intragenic pathogenic variants [Cai et al 2003a]; individuals with a TWIST1 deletion and normal development have been reported [de Heer et al 2005, Kress et al 2006].


Precise penetrance data are not available; however, wide phenotypic variability and incomplete penetrance are well described [Dollfus et al 2002, de Heer et al 2005].


Robinow-Sorauf syndrome is now known to be caused by pathogenic variants in TWIST1 [Cai et al 2003b] and is considered part of the mild end of the phenotypic spectrum of SCS.


SCS is one of the more common forms of syndromic craniosynostosis. Prevalence estimates range from 1:25,000 to 1:50,000. It is generally agreed that SCS has approximately the same prevalence as Crouzon syndrome.

Variability of the SCS phenotype may result in underdiagnosis.

Differential Diagnosis

Muenke syndrome is a distinct condition caused by the specific single-nucleotide variant p.Pro250Arg in FGFR3 (encoding fibroblast growth factor receptor 3) [Muenke et al 1997]. Penetrance is reduced [Paznekas et al 1998].

  • Both Muenke syndrome and Saethre-Chotzen syndrome (SCS) share the features of unilateral or bilateral coronal synostosis.
  • Individuals with Muenke syndrome do not have the following features of SCS: distinctive facial features, including low-set frontal hairline, downward sloping palpebral fissures; ptosis; ear abnormalities; interdigital webbing. In their study of 39 pedigrees (71 affected individuals) ascertained on the basis of coronal synostosis, Kress et al [2006] determined that individuals with a TWIST1 pathogenic variant could be distinguished from those with the FGFR3 p.Pro250Arg pathogenic variant based on differences in facial features.
  • Compared to persons with SCS, individuals with Muenke syndrome may have a higher prevalence of developmental delay (35% vs 5%) and sensorineural hearing loss (34% vs 0%).

Because clinical findings of Muenke syndrome and Saethre-Chotzen syndrome overlap, testing for the FGFR3 p.Pro250Arg pathogenic variant should be considered if no TWIST1 pathogenic variant is identified in an individual with a presumed diagnosis of Saethre-Chotzen syndrome (see Muenke Syndrome).

Isolated unilateral coronal synostosis. Coronal synostosis is the second most common form of single-suture fusion after sagittal synostosis. Isolated coronal synostosis refers to coronal suture fusion with no evidence of other malformations. Isolated coronal fusion is approximately ten times more common than SCS; if left untreated or incompletely treated, it can result in facial asymmetry resembling SCS.

Baller-Gerold syndrome (BGS) is characterized by bilateral coronal craniosynostosis that results in brachycephaly with ocular proptosis and flat forehead; radial ray defect, usually with oligodactyly (reduction in number of digits), aplasia or hypoplasia of the thumb, and/or aplasia or hypoplasia of the radius; growth retardation; and poikiloderma. Findings in individuals with BGS overlap with those of Rothmund-Thomson syndrome (RTS) and RAPADILINO syndrome, all of which are caused by pathogenic variants in RECQL4. Inheritance is autosomal recessive.

In an analysis of 186 individuals with isolated single-suture craniosynostosis, 7.5% had at least one rare deletion or duplication found using aCGH [Mefford et al 2010].


Evaluations Following Initial Diagnosis

To establish the extent of disease in an individual diagnosed with Saethre-Chotzen syndrome (SCS), the following evaluations are recommended:

  • Determination of the degree of facial asymmetry to establish a baseline for future recognition of progressive facial asymmetry
  • Ophthalmologic examination for evaluation of ptosis, strabismus, amblyopia, lacrimal duct stenosis, and increased ICP [Woods et al 2009]
  • Screening for vertebral (particularly cervical) anomalies using routine radiographs (At age ~2 years, increased mineralization of the vertebrae allows for better interpretation of flexion/extension views of the cervical spine in evaluation for functional instability.)
  • Audiologic screening for hearing loss
  • Examination for cleft palate; if cleft palate is present, assessment of feeding ability and growth
  • Examination of upper and lower extremities for anomalies; if anomalies are present, x-ray and/or orthopedic evaluation for radial ray or hallux anomalies
  • Measurement of height and growth velocity; if short stature and/or reduced linear growth velocity is present, evaluation by an endocrinologist
  • Screening developmental assessment on any child demonstrating developmental delays and all children found to have a 7p microdeletion, if developmental delay is identified, comprehensive developmental assessment

Treatment of Manifestations

As with all children with functional craniofacial malformations, management through an established craniofacial team is recommended.

While management protocols are likely to differ among craniofacial teams, it is generally accepted that individuals with SCS should undergo cranioplasty in the first year of life.

Cranioplasty involves extensive surgery to release fused sutures including repositioning and reconstruction of the malformed calvaria. It prevents the following:

  • Progressive facial asymmetry that can develop in individuals with unilateral or asymmetric coronal fusion
  • Increased intracranial pressure (ICP) that can develop in individuals with multiple sutural synostosis (bicoronal or other sutures)
  • Progressive hypertropia resulting from overaction of the ipsilateral inferior oblique muscle in cases of unilateral coronal synostosis [Weiss & Phillips 2006].

In some circumstances, midfacial surgery is necessary during childhood to address dental malocclusion, swallowing difficulties, or respiratory problems.

If cleft palate is present, it is treated as in other disorders, including surgical closure, assurance of adequate feeding and weight gain, and speech therapy. In most cases, cranioplasty precedes palatal repair.

Orthodontic treatment and/or orthognathic surgery may be required at or near the completion of facial growth.

If developmental delay is identified, early intervention and/or special education are appropriate.

Hearing loss, if present, should be treated in a standard manner (see Deafness and Hereditary Hearing Loss Overview).

Ophthalmologic abnormalities are treated in a standard fashion. Ptosis and strabismus should be corrected during early childhood to prevent amblyopia, either with patching or surgery.

Prevention of Secondary Complications

Early referral to a craniofacial center with expertise in the management of SCS can minimize the secondary effects of craniosynostosis and other functional deficits. Referral to early intervention services if there are concerns for developmental delay is appropriate to improve outcome.

Tympanostomy tubes are appropriate for children with cleft palate or other causes of persistent middle ear effusion and/or otitis media.

Cervical spine radiograph to evaluate for segmentation defects is appropriate before initiating activities that put the spine at risk (e.g., gymnastics, football, soccer).


Because increased intracranial pressure (ICP) can develop even after successful treatment of craniosynostosis, brain imaging or ophthalmologic evaluation for chronic papilledema should be obtained periodically until age 15 years, or at any time symptoms (e.g., headache, reduced school performance) are identified.

Examination for progression of facial asymmetry particularly in individuals with untreated unilateral coronal synostosis should continue until the completion of facial growth (age ~16 years).

Audiologic screening throughout childhood is indicated.

Regular ophthalmologic evaluations (frequency determined on the basis of symptoms) should begin before age two years or earlier if strabismus or severe ptosis is identified.

If cleft palate is present, monitor for ear infections and hearing loss.

Screen for sleep-disordered breathing at all visits.

At least annual assessment of developmental status of preschool-aged children is appropriate. If findings suggest developmental delay, comprehensive developmental assessment and referral to early intervention is indicated.

Evaluation of Relatives at Risk

See Genetic Counseling for issues related to testing of at-risk relatives for genetic counseling purposes.

Therapies Under Investigation

Search for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.

Genetic Counseling

Genetic counseling is the process of providing individuals and families with information on the nature, inheritance, and implications of genetic disorders to help them make informed medical and personal decisions. The following section deals with genetic risk assessment and the use of family history and genetic testing to clarify genetic status for family members. This section is not meant to address all personal, cultural, or ethical issues that individuals may face or to substitute for consultation with a genetics professional. —ED.

Mode of Inheritance

Saethre-Chotzen syndrome (SCS) is inherited in an autosomal dominant manner.

Risk to Family Members

Parents of a proband

  • Many individuals diagnosed with SCS have an affected parent.
  • A proband with SCS may have the disorder as the result of a de novo pathogenic variant. The proportion of cases caused by de novo pathogenic variants is unknown.
  • Recommendations for the evaluation of parents of a proband with an apparent de novo pathogenic variant include the following:
    • Complete examination for subtle features (ptosis, mild brachydactyly/2-3 syndactyly) even in the absence of any calvarial pathology
    • Molecular genetic testing of TWIST1 if a pathogenic variant has been identified in the proband

Note: Although many individuals diagnosed with SCS have an affected parent, the family history may appear to be negative because of failure to recognize the disorder in family members as a result of the wide phenotypic variability of SCS.

Sibs of a proband

  • The risk to sibs depends on the genetic status of the parents.
  • If a parent has SCS, the risk to each sib of a proband is 50%.
  • When the parents are clinically unaffected and do not have a TWIST1 pathogenic variant, the risk to the sibs of a proband appears to be low.
  • If a TWIST1 pathogenic variant cannot be detected in DNA extracted from the leukocytes of either parent of the proband, two possible explanations are germline mosaicism in a parent or a de novo pathogenic variant in the proband. The risk to the sibs of the proband depends on the probability of germline mosaicism in a parent of the proband and the spontaneous mutation rate of TWIST1. No instances of germline mosaicism have been reported, although it remains a possibility.

Offspring of a proband. Each child of an individual with SCS has a 50% chance of inheriting the pathogenic variant.

Other family members of a proband. The risk to other family members depends on the status of the proband's parents. If a parent is affected, his or her family members are at risk.

Related Genetic Counseling Issues

The widely variable phenotypic manifestations of TWIST1 pathogenic variants (intra- and interfamilial) complicate genetic counseling.

Considerations in families with an apparent de novo pathogenic variant. When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder or the pathogenic variant, it is likely that the proband has a de novo pathogenic variant. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.

Family planning

  • The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.
  • It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.

DNA banking is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.

Prenatal Testing

Molecular genetic testing. Once the pathogenic variant has been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk is possible.

Requests for prenatal testing for conditions such as SCS are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although decisions about prenatal testing are the choice of the parents, discussion of these issues is appropriate.


GeneReviews staff has selected the following disease-specific and/or umbrella support organizations and/or registries for the benefit of individuals with this disorder and their families. GeneReviews is not responsible for the information provided by other organizations. For information on selection criteria, click here.

  • FACES: The National Craniofacial Association
    PO Box 11082
    Chattanooga TN 37401
    Phone: 800-332-2373 (toll-free)
  • AboutFace International
    123 Edward Street
    Suite 1003
    Toronto Ontario M5G 1E2
    Phone: 800-665-3223 (toll-free); 416-597-2229
    Fax: 416-597-8494
  • American Society for Deaf Children (ASDC)
    800 Florida Avenue Northeast
    Suite 2047
    Washington DC 20002-3695
    Phone: 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)
    Fax: 410-795-0965
  • Children's Craniofacial Association (CCA)
    13140 Coit Road
    Suite 517
    Dallas TX 75240
    Phone: 800-535-3643 (toll-free); 214-570-9099
    Fax: 214-570-8811
  • FACES: The National Craniofacial Association
    PO Box 11082
    Chattanooga TN 37401
    Phone: 800-332-2373 (toll-free)
  • National Association of the Deaf (NAD)
    8630 Fenton Street
    Suite 820
    Silver Spring MD 20910
    Phone: 301-587-1788; 301-587-1789 (TTY)
    Fax: 301-587-1791

Molecular Genetics

Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. —ED.

Table A.

Saethre-Chotzen Syndrome: Genes and Databases

GeneChromosome LocusProteinLocus-Specific DatabasesHGMDClinVar
TWIST17p21​.1Twist-related protein 1TWIST1 databaseTWIST1TWIST1

Data are compiled from the following standard references: gene from HGNC; chromosome locus from OMIM; protein from UniProt. For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click here.

Table B.

OMIM Entries for Saethre-Chotzen Syndrome (View All in OMIM)


Molecular Genetic Pathogenesis

Little is known about the mechanism by which alteration in Twist-related protein 1 signaling pathways leads to craniosynostosis.

Clinically, Saethre-Chotzen syndrome (SCS) has phenotypic overlap with other craniosynostosis syndromes, particularly Muenke syndrome, caused by the p.Pro250Arg pathogenic variant in FGFR3 [Muenke et al 1997]. Although clinically leading to the same primary malformation, premature fusion of the calvaria, it is not known if the two genes lie in the same, parallel, or independent pathways during calvarial development.

Several genes and gene families, including TWIST1, FGFs, FGFRs, MSX2, ALX4, EFNB1, EFNA4, NELL1, RUNX2, BMPs, TGF-ßs, SHH, IGFs, IGFRs, and IGFBPs regulate suture patency, likely by interacting with one another. One model proposes that Twist-related protein 1 functions by forming either homodimers or heterodimers that have distinct regulatory interactions with other genes, such as FGFRs and BMPs. Haploinsufficiency of Twist-related protein 1 changes the ratio of dimers and, therefore, the expression of downstream signaling molecules. This model also supports the finding that the coronal sutures are predominantly fused in SCS, since these sutures have a higher level of gene expression of downstream activators, as shown in mice models [Connerney et al 2008, Miraoui & Marie 2010].

Gene structure. TWIST1 comprises two exons and one intron. The first exon contains an open reading frame encoding a 202-amino acid protein, followed by a 45-bp untranslated portion, a 536-bp intron, and a second untranslated exon (Reference sequences NM_000474.3 and NP_000465.1).

Benign variants. At least 50 normal variants have been identified within TWIST1 [Fredman et al 2002]. Of these, eight intragenic normal variants have been identified within the coding region [Kasparcova et al 1998, Gripp et al 2000, SNP Database]. In addition, Elanko et al [2001] described a variation in the polyglycine tract length of TWIST1 in individuals with craniosynostosis. None of these rearrangements was consistently associated with clinical disease; thus, they were considered benign variants or at most weakly pathogenic variants.

Pathogenic variants. To date, 126 variants in TWIST1 have been determined to cause SCS, which results from functional haploinsufficiency of Twist-related protein 1, a basic helix-loop-helix (HLH) transcription factor. These include 73 distinct nucleotide substitutions (missense and nonsense), 53 deletions/insertions/duplications/indels, and complex rearrangements [Johnson et al 1998, Zackai & Stolle 1998, Gripp et al 2000, Chun et al 2002, Seto et al 2007, Human Gene Mutation Database 2011 (registration required)].

All of the single-nucleotide variants are located within the coding region; no splice variants, intronic variants, or changes within the second exon have been reported. No apparent mutational "hot spot" has been identified.

  • Nonsense variants that preclude translation of the DNA binding domain and the HLH domain have been identified from the 5' end of the coding sequence to the end of the HLH motif.
  • Missense variants are clustered within the functional domains.
  • Four persons have been identified with pathogenic variants in the C-terminus, known as the TWIST box, a highly conserved region which binds and inhibits RUNX2 activation [Kress et al 2006, Seto et al 2007, Peña et al 2010]. RUNX2 is considered the “master switch” for osteoblast differentiation and activity. The individuals with TWIST box pathogenic variants had single suture synostosis (one sagittal and one unilateral coronal) and no additional features of SCS.

Normal gene product. The Twist-related protein 1 is a member of a large family of basic helix-loop-helix (bHLH) transcriptional regulators. The bHLH motif is identified by the basic domain that mediates specific DNA binding, the HLH domains containing two amphipathic helices that act as dimerization domains [Murre et al 1994], and a loop region that separates the two helices. A motif of mainly basic residues permits HLH protein to bind to a consensus hexanucleotide E-box (CANNTG) [Voronova & Baltimore 1990]. Dimerization is a prerequisite for DNA binding; it depends on the spacing between the helices and leads to the formation of a bipartite DNA-binding groove by the basic domain.

Abnormal gene product. Germline TWIST1 pathogenic variants lead to haploinsufficiency [el Ghouzzi et al 2000].

  • Nonsense variants predict the synthesis of truncated proteins or nonsense-mediated mRNA decay and result in a lack of abnormal protein, thereby leading to functional haploinsufficiency.
  • Missense variants involving the helical domains lead to a loss of heterodimer formation that alters nuclear translocation.
  • In-frame insertion or missense variants within the loop domain alter dimer formation, but not the nuclear location of the protein.

These data suggest that protein degradation and altered subcellular localization account for the loss of functional Twist-related protein 1 from the mutated allele in individuals with SCS. The suggestion is further supported by the finding of premature fusion of sutures in twist-null/+ heterozygous mice [el Ghouzzi et al 1997, Bourgeois et al 1998, Carver et al 2002].

Click here for information on animal models (pdf).


Literature Cited

  • Anderson PJ, Hall CM, Evans RD, Hayward RD, Harkness WJ, Jones BM. The cervical spine in Saethre-Chotzen syndrome. Cleft Palate Craniofac J. 1997;34:79–82. [PubMed: 9003917]
  • Bourgeois P, Bolcato-Bellemin AL, Danse JM, Bloch-Zupan A, Yoshiba K, Stoetzel C, Perrin-Schmitt F. The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome. Hum Mol Genet. 1998;7:945–57. [PubMed: 9580658]
  • Cai J, Goodman BK, Patel AS, Mulliken JB, Van Maldergem L, Hoganson GE, Paznekas WA, Ben-Neriah Z, Sheffer R, Cunningham ML, Daentl DL, Jabs EW. Increased risk for developmental delay in Saethre-Chotzen syndrome is associated with TWIST deletions: an improved strategy for TWIST mutation screening. Hum Genet. 2003a;114:68–76. [PubMed: 14513358]
  • Cai J, Shoo BA, Sorauf T, Jabs EW. A novel mutation in the TWIST gene, implicated in Saethre-Chotzen syndrome, is found in the original case of Robinow-Sorauf syndrome. Clin Genet. 2003b;64:79–82. [PubMed: 12791045]
  • Carver EA, Oram KF, Gridley T. Craniosynostosis in Twist heterozygous mice: a model for Saethre-Chotzen syndrome. Anat Rec. 2002;268:90–2. [PubMed: 12221714]
  • Chun K, Teebi AS, Jung JH, Kennedy S, Laframboise R, Meschino WS, Nakabayashi K, Scherer SW, Ray PN, Teshima I. Genetic analysis of patients with the Saethre-Chotzen phenotype. Am J Med Genet. 2002;110:136–43. [PubMed: 12116251]
  • Connerney J, Andreeva V, Leshem Y, Mercado MA, Dowell K, Yang X, Linder V, Friesel RE, Spicer DB. Twist1 homodimers enhance FGF responsiveness of the cranial sutures and promote suture closure. Developmental Biology. 2008;318:323–34. [PMC free article: PMC2605972] [PubMed: 18471809]
  • de Heer IM, de Klein A, van den Ouweland AM, Vermeij-Keers C, Wouters CH, Vaandrager JM, Hovius SE, Hoogeboom JM. Clinical and genetic analysis of patients with Saethre-Chotzen syndrome. Plast Reconstr Surg. 2005;115:1894–902. [PubMed: 15923834]
  • De Heer IM, Hoogeboom AJ, Eussen HJ, Vaandrager JM, De Klein A. Deletion of the TWIST gene in a large five-generation family. Clin Genet. 2004;65:396–9. [PubMed: 15099347]
  • de Jong T, Bannink N, Bredero-Boelhouwer HH, van Veelen MLC, Bartels MC, Hoeve LJ, Hoogeboom AJM, Wolvius EB, Lequin MH, van der Muelen JJNM, van Adrichem LNA, Vaandrager JM, Ongkosuwito EM, Joosten KFM, Mathijssen IMJ. Long-term functional outcome in 167 patients with syndromic craniosynostosis; defining a syndrome-specific risk profile. J Plast Reconstr Aesthet Surg. 2010;63:1635–41. [PubMed: 19913472]
  • Dollfus H, Biswas P, Kumaramanickavel G, Stoetzel C, Quillet R, Biswas J, Lajeunie E, Renier D, Perrin-Schmitt F. Saethre-Chotzen syndrome: notable intrafamilial phenotypic variability in a large family with Q28X TWIST mutation. Am J Med Genet. 2002;109:218–25. [PubMed: 11977182]
  • el Ghouzzi V, Le Merrer M, Perrin-Schmitt F, Lajeunie E, Benit P, Renier D, Bourgeois P, Bolcato-Bellemin AL, Munnich A, Bonaventure J. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat Genet. 1997;15:42–6. [PubMed: 8988167]
  • el Ghouzzi V, Legeai-Mallet L, Aresta S, Benoist C, Munnich A, de Gunzburg J, Bonaventure J. Saethre-Chotzen mutations cause TWIST protein degradation or impaired nuclear location. Hum Mol Genet. 2000;9:813–9. [PubMed: 10749989]
  • Elanko N, Sibbring JS, Metcalfe KA, Clayton-Smith J, Donnai D, Temple IK, Wall SA, Wilkie AO. A survey of TWIST for mutations in craniosynostosis reveals a variable length polyglycine tract in asymptomatic individuals. Hum Mutat. 2001;18:535–41. [PubMed: 11748846]
  • Fredman D, Siegfried M, Yuan YP, Bork P, Lehvaslaiho H, Brookes AJ. HGVbase: a human sequence variation database emphasizing data quality and a broad spectrum of data sources. Nucleic Acids Res. 2002;30:387–91. [PMC free article: PMC99093] [PubMed: 11752345]
  • Gripp KW, Kasparcova V, McDonald-McGinn DM, Bhatt S, Bartlett SP, Storm AL, Drumheller TC, Emanuel BS, Zackai EH, Stolle CA. A diagnostic approach to identifying submicroscopic 7p21 deletions in Saethre-Chotzen syndrome: fluorescence in situ hybridization and dosage-sensitive Southern blot analysis. Genet Med. 2001;3:102–8. [PubMed: 11280946]
  • Gripp KW, Stolle CA, Celle L, McDonald-McGinn DM, Whitaker LA, Zackai EH. TWIST gene mutation in a patient with radial aplasia and craniosynostosis: further evidence for heterogeneity of Baller-Gerold syndrome. Am J Med Genet. 1999;82:170–6. [PubMed: 9934984]
  • Gripp KW, Zackai EH, Stolle CA. Mutations in the human TWIST gene. Hum Mutat. 2000;15:479. [PubMed: 10790211]
  • James PA, Culling B, Mullan G, Jenkins M, Elakis G, Turner AM, Mowat DM, Wilson M, Anderson P, Savarirayan R, Cliffe ST, Caramins M, Buckley MF, Tucker K, Roscioli T. Breast cancer risk is not increased in individuals with TWIST1 mutation confirmed Saethre-Chotzen syndrome: an Australian multicenter study. Genes Chromosomes Cancer. 2009;48:533–8. [PubMed: 19373776]
  • Johnson D, Horsley SW, Moloney DM, Oldridge M, Twigg SR, Walsh S, Barrow M, Njolstad PR, Kunz J, Ashworth GJ, Wall SA, Kearney L, Wilkie AO. A comprehensive screen for TWIST mutations in patients with craniosynostosis identifies a new microdeletion syndrome of chromosome band 7p21.1. Am J Hum Genet. 1998;63:1282–93. [PMC free article: PMC1377539] [PubMed: 9792856]
  • Kasparcova V, Stolle CA, Gripp KW, Celle L, McDonald-McGinn D, Bartlett S, Whitaker L, Zackai EH. Molecular analysis of patients with Saethre-Chotzen syndrome: novel mutations and polymorphisms in the TWIST gene. Am J Med Genet. 1998;63:A367.
  • Kress W, Schropp C, Lieb G, Petersen B, Busse-Ratzka M, Kunz J, Reinhart E, Schafer WD, Sold J, Hoppe F, Pahnke J, Trusen A, Sorensen N, Krauss J, Collmann H. Saethre-Chotzen syndrome caused by TWIST 1 gene mutations: functional differentiation from Muenke coronal synostosis syndrome. Eur J Hum Genet. 2006;14:39–48. [PubMed: 16251895]
  • Kunz J, Hudler M, Fritz B. Identification of a frameshift mutation in the gene TWIST in a family affected with Robinow-Sorauf syndrome. J Med Genet. 1999;36:650–2. [PMC free article: PMC1762975] [PubMed: 10465122]
  • Lee S, Seto M, Sie K, Cunningham M. A child with Saethre-Chotzen syndrome, sensorineural hearing loss, and a TWIST mutation. Cleft Palate Craniofac J. 2002;39:110–4. [PubMed: 11772178]
  • Mefford HC, Shafer N, Antonacci F, Tsai JM, Park SS, Hing AV, Rieder MJ, Smyth MD, Speltz ML, Eichler EE, Cunningham ML. Copy number variation analysis in single-suture craniosynostosis: multiple rare variants Including RUNX2 duplication in two cousins with metopic craniosynostosis. Am J Med Genet Part A. 2010;152A:2203–10. [PMC free article: PMC3104131] [PubMed: 20683987]
  • Miraoui H, Marie PJ. Pivotal role of Twist in skeletal biology and pathology. Gene. 2010;468:1–7. [PubMed: 20696219]
  • Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, Markowitz RI, Robin NH, Nwokoro N, Mulvihill JJ, Losken HW, Mulliken JB, Guttmacher AE, Wilroy RS, Clarke LA, Hollway G, Ades LC, Haan EA, Mulley JC, Cohen MM Jr, Bellus GA, Francomano CA, Moloney DM, Wall SA, Wilkie AO, et al. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet. 1997;60:555–64. [PMC free article: PMC1712518] [PubMed: 9042914]
  • Murre C, Bain G, van Dijk MA, Engel I, Furnari BA, Massari ME, Matthews JR, Quong MW, Rivera RR, Stuiver MH. Structure and function of helix-loop-helix proteins. Biochim Biophys Acta. 1994;1218:129–35. [PubMed: 8018712]
  • Paznekas WA, Cunningham ML, Howard TD, Korf BR, Lipson MH, Grix AW, Feingold M, Goldberg R, Borochowitz Z, Aleck K, Mulliken J, Yin M, Jabs EW. Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am J Hum Genet. 1998;62:1370–80. [PMC free article: PMC1377134] [PubMed: 9585583]
  • Peña WA, Slavotinek A, Oberoi S. Saethre-Chotzen syndrome: a case report. Cleft Palate Craniofac J. 2010;47:318–21. [PubMed: 19860490]
  • Sahlin P, Windh P, Lauritzen C, Emanuelsson M, Gronberg H, Stenman G. Women with Saethre-Chotzen syndrome are at increased risk of breast cancer. Genes Chromosomes Cancer. 2007;46:656–60. [PubMed: 17437280]
  • Schluth-Bolard C, Till M, Labalme A, Rey C, Banquart E, Fautrelle A, Martin-Denavit T, Le Lorc’h M, Romana SP, Lazar V, Edery P, Sanlaville D. TWIST microdeletion identified by array CGH in a patient presenting Saethre-Chotzen phenotype and a complex rearrangement involving chromosomes 2 and 7. Eur J Med Genet. 2008;51:156–64. [PubMed: 18255367]
  • Seto ML, Hing AV, Chang J, Hu M, Kapp-Simon KA, Patel PK, Burton BK, Kane AA, Smyth MD, Hopper R, Ellenbogen RG, Stevenson K, Speltz ML, Cunningham ML. Isolated sagittal and coronal craniosynostosis associated with TWIST box mutations. Am J Med Genet A. 2007;143A:678–86. [PubMed: 17343269]
  • Seto ML, Lee SJ, Sze RW, Cunningham ML. Another TWIST on Baller-Gerold syndrome. Am J Med Genet. 2001;104:323–30. [PubMed: 11754069]
  • Shetty S, Boycott KM, Gillan TL, Bowser K, Parboosingh JS, McInnes B, Chernos JE, Bernier FP. Cytogenetic and molecular characterization of a de-novo cryptic deletion of 7p21 associated with an apparently balanced translocation and complex craniosynostosis. Clin Dysmorphol. 2007;16:253–6. [PubMed: 17786117]
  • Stoler JM, Rogers GF, Mulliken JB. The frequency of palatal anomalies in Saethre-Chotzen syndrome. Cleft Palate Craniofac J. 2009;46:280–4. [PubMed: 19642760]
  • Touliatou V, Mavrou A, Kolialexi A, Kanavakis E, Kitsiou-Tzeli S. Saethre-Chotzen syndrome with severe developmental delay associated with deletion of chromosomic region 7p15→pter. Genet Couns. 2007;18:295–301. [PubMed: 18019370]
  • Trusen A, Beissert M, Collmann H, Darge K. The pattern of skeletal anomalies in the cervical spine, hands and feet in patients with Saethre-Chotzen syndrome and Muenke-type mutation. Pediatr Radiol. 2003;33:168–72. [PubMed: 12612814]
  • Voronova A, Baltimore D. Mutations that disrupt DNA binding and dimer formation in the E47 helix-loop-helix protein map to distinct domains. Proc Natl Acad Sci U S A. 1990;87:4722–6. [PMC free article: PMC54189] [PubMed: 2112746]
  • Weiss AH, Phillips JO. Hypertropia associated with superolateral translation of the superior rectus muscle pulley in unilateral coronal synostosis. Arch Ophthalmol. 2006;124:1128–34. [PubMed: 16908815]
  • Woods RH, Ul-Haq E, Wilkie AOM, Jayamohan J, Richards PG, Johnson D, Lester T, Wall SA. Reoperation for intracranial hypertension in TWIST1-confirmed Saethre-Chotzen syndrome: a 15-year review. Plast Reconstr Surg. 2009;123:1801–10. [PMC free article: PMC2719244] [PubMed: 19483581]
  • Zackai EH, Stolle CA. A new twist: some patients with Saethre-Chotzen syndrome have a microdeletion syndrome. Am J Hum Genet. 1998;63:1277–81. [PMC free article: PMC1377538] [PubMed: 9792855]

Suggested Reading

  • Couly GF, Coltey PM, Le Douarin NM. The developmental fate of the cephalic mesoderm in quail-chick chimeras. Development. 1992;114:1–15. [PubMed: 1576952]
  • Couly GF, Coltey PM, Le Douarin NM. The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development. 1993;117:409–29. [PubMed: 8330517]
  • Hebrok M, Wertz K, Fuchtbauer EM. M-twist is an inhibitor of muscle differentiation. Dev Biol. 1994;165:537–44. [PubMed: 7958419]
  • Jan YN, Jan LY. HLH proteins, fly neurogenesis, and vertebrate myogenesis. Cell. 1993;75:827–30. [PubMed: 8252617]
  • Lee JE, Hollenberg SM, Snider L, Turner DL, Lipnick N, Weintraub H. Conversion of xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science. 1995;268:836–44. [PubMed: 7754368]
  • Murray SS, Glackin CA, Winters KA, Gazit D, Kahn AJ, Murray EJ. Expression of helix-loop-helix regulatory genes during differentiation of mouse osteoblastic cells. J Bone Miner Res. 1992;7:1131–8. [PubMed: 1280901]
  • Olson EN, Klein WH. bHLH factors in muscle development: deadlines and commitments, what to leave in and what to leave out. Genes Dev. 1994;8:1–8. [PubMed: 8288123]
  • Pantke OA, Cohen MM Jr, Witkop CJ Jr, Feingold M, Schaumann B, Pantke HC, Gorlin RJ. The Saethre-Chotzen syndrome. Birth Defects Orig Artic Ser. 1975;11:190–225. [PubMed: 1227525]

Chapter Notes

Revision History

  • 14 June 2012 (cd) Revision: mutation scanning no longer available clinically
  • 21 June 2011 (me) Comprehensive update posted live
  • 27 December 2007 (me) Comprehensive update posted to live Web site
  • 1 August 2005 (me) Comprehensive update posted to live Web site
  • 30 July 2004 (mc) Revision: testing methods
  • 16 May 2003 (me) Review posted to live Web site
  • 21 January 2003 (mc) Original submission
Copyright © 1993-2018, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source ( and copyright (© 1993-2018 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

Bookshelf ID: NBK1189PMID: 20301368


  • PubReader
  • Print View
  • Cite this Page
  • Disable Glossary Links

Tests in GTR by Condition

Related information

  • MedGen
    Related information in MedGen
  • OMIM
    Related OMIM records
  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed
  • Gene
    Locus Links

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...